Industry News - Tag: AFT

You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

AFT grows by 7% as Maxigesic rollout progresses
Premium

28 May 2021

AFT Pharmaceuticals reported sales up by 7% to NZD113 million (USD81.6 million) in the 12 months ended 31 March 2021. The New Zealand company said the tablet version of its Maxigesic combination painkiller was available in 43 countries at the end of the 12-month period, up from 28 a year earlier.

Read the full story

AFT strikes deal with Poland’s Mercapharm
Premium

8 April 2021

New Zealand’s AFT Pharmaceuticals has signed a licensing agreement for its Maxigesic combination painkiller with Polish company Mercapharm. The company has also revised its financial guidance following delays and disruptions related to the COVID-19 pandemic.

Read the full story